| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |